Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma

The current developments of the new biological drugs targeting interleukin 5 (IL-5) and IL-5 receptor allowed to expand the treatment options for severe hypereosinophilic asthma. Clinicians will then be able to choose between antibodies targeting either circulating IL-5 or its receptor expressed on...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagnasco, Diego, Caminati, Marco, Ferrando, Matteo, Aloè, Teresita, Testino, Elisa, Canonica, Giorgio Walter, Passalacqua, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241368/
https://www.ncbi.nlm.nih.gov/pubmed/30519580
http://dx.doi.org/10.1155/2018/5698212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241368/
https://www.ncbi.nlm.nih.gov/pubmed/30519580
http://dx.doi.org/10.1155/2018/5698212

Ejemplares similares